The role of benzodiazepine receptors in the acquisition and expression of behavioral sensitization to methamphetamine

Pharmacology Biochemistry and Behavior

Volumn 65, Issue 4, 2000, Pages 705-710

  Ito, K ^a   Ohmori, T ^a   Abekawa, T ^a   Koyama, T ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Benzodiazepine; Clonazepam; Flumazenil; GABA; Methamphetamine; Sensitization

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE RECEPTOR; CLONAZEPAM; FLUMAZENIL; METHAMPHETAMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; LEARNING; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CLONAZEPAM; FLUMAZENIL; GABA MODULATORS; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, GABA-A;

EID: 0034108853     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00263-4     Document Type: Article

References (39)

1. Baldy-Moulinier M., Lerner-Natoli M., Rondouin G., Privat A., Benattia M., Heaulme M., Chicheportiche R. GABA and limbic system kindling. Bartholini G., Bossi L., Lloyd G.K., Morselli P.L. L.E.R.S., vol 3. 1985;187-193 Raven Press, New York.
2. Barondes S.H. Cerebral protein synthesis inhibitors block long-term memory. Int. Rev. Neurobiol. 12:1970;177-205.
3. Bedingfield J.B., Calder L.D., Thai D.K., Karler R. The role of the striatum in the mouse in behavioral sensitization to amphetamine. Pharmacol. Biochem. Behav. 56:1997;305-310.
4. Bonetti E.P., Pieri L., Cumin R., Schaffner R., Pieri M., Gamzu E.R., Müller R.K.M., Haefely W. Benzodiazepine antagonist Ro 15-1788. Neurological and behavioral effects Psychpharmacology (Berlin). 78:1982;8-18.
5. Britton K.T., Lee G., Koob G.F. Corticotrophin releasing factor and amphetamine exaggerate partial agonist properies of benzodiazepine antagonist Ro15-1788 in the conflict test. Psycho-pharmacology (Berlin). 94:1988;306-311.
6. Brogden R.N., Goa K.L. Flumazenil. A preliminary review of its benzodiazepine antagonist properties, intrinsic activity and therapeutic use Drugs. 35:1988;448-467.
7. Dingledine R., McBain C.J., McNamara J.O. Excitatory amino acid receptors in epilepsy. Trend Pharmacol. Sci. 11:1990;334-338.
8. Elrod K., Buccafusco J. An evaluation of mechanism of scopolamine-induced impairment in two passive avoidance protocols. Biochem. Behav. 29:1988;15-21.
9. File S.E., Pellow S. Intrinsic actions of benzodiazepine receptor antagonist Ro 15-1788. Psychopharmacology (Berlin). 88:1986;1-11.
10. Guidotti A., Forchetti C.M., Corda M.G. Isolation, characterization and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc. Natl. Acad. Sci. USA. 80:1983;3531-3533.
11. Hirotsu I., Hori N., Katsuda N., Ishihara T. Effect of anticholinergic drug on long-term potentiation in rat hippocampal slices. Brain Res. 482:1989;194-197.
12. Invernizzi R., Pozzi L., Samanin R. Release of dopamine is reduced by diazepam more in the nucleus accumbens than in the caudate nucleus of conscious rats. Neuropharmacology. 30:1991;575-578.
13. Ito K., Ohmori T., Abekawa T., Koyama T. Clonazepam prevents sensitization to methamphetamine. Pharmacol. Biochem. Behav. 58:1997;875-879.
14. James G., Barbee M.D. Memory, benzodiazepines, and anxiety. Integration of theoretical and clinical perspectives J. Clin. Psychiatry (Suppl.). 54:1993;86-97.
15. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
16. Kalivas P.W., Sorg B.A., Hooks M.S. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav. Parmacol. 4:1993;315-334.
17. Karler R., Calder L.D., Chaudhry I.A., Turkanis S.A. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci. 45:1989;599-606.
18. Karler R., Finnegan K.T., Calder L.D. Blockade behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis. Brain Res. 603:1993;19-24.
19. Karler R., Bedingfield J.B., Thai D.K., Calder L.D. The role of the frontal cortex in the mouse in behavioral sensitization to amphetamine. Brain Res. 757:1997;228-235.
20. Kavaliers M., Hirst M. An octadecaneuropeptide (OND) derived from diazepam binding inhibitor increases aggressive interactions in mice. Brain Res. 383:1986;343-349.
21. Malenka R.C., Nicoll R.A. NMDA-receptor-dependent synaptic plasticity; multiple forms and mechanisms. Trend Neurosci. 16:1993;521-527.
22. Martini C., Lucacchini A., Hrelia S., Rossi C.A. Central- and peripheral-type benzodiazepine receptors. Biggio G., Costa E. GABAergic transmission and anxiety. 1986;1-10 Raven Press, New York.
23. Mccarty R., Kopin I.J. Alterations in plasma catecholamines and behavior during acute stress in spontaneously hypertensive and Wister-Kyoto normotensive rats. Life Sci. 22:1978;997-1006.
24. McEntee W.J., Crook T.H. Glutamate. Its role in learning, memory and the aging brain Psychopharmacology (Berlin). 111:1993;391-401.
25. Nilsson A., Persson M.P., Hartvig P. Effects of the benzodiazepine antagonist flumazenil on postoperative performance following total intravenous anesthesia with midazolam and alfentanil. Acta Anesth. Scand. 32:1988;441-446.
26. Ohmori T., Abekawa T., Koyama T. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine. Pharmacol. Biochem. Behav. 48:1994;587-591.
27. Ohmori T., Abekawa T., Koyama T. Scopolamine prevents augmentation of stereotypy induced by chronic methamphetamine treatment. Psychopharmacology (Berlin). 121:1995;158-163.
28. Ohmori T., Abekawa T., Koyama T. Scopolamine prevents the development of sensitization to methamphetamine. Life Sci. 56:1995;1223-1229.
29. Otani S., Roisin-Lallemand M.P., Ben-Ari Y. Enhancement of extracellular protein concentrations during long-term potentiation in the rat hippocampal slice. Neuroscience. 47:1992;265-272.
30. Quinton E.E., Kramarcy N.R. Memory impairment correlates closely with cycloheximide dose and degree of inhibition of protein synthesis. Brain Res. 131:1977;184.
31. Pierce R.C., Kalivas R.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25:1997;192-216.
32. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration. A review and evaluation of animal models of amphetamine psychosis Brain Res. Rev. 11:1986;157-198.
33. Robinson, T. E.: Biological basis of schizophrenic disorders. In: Nakazawa, T., ed. Tokyo: Japan Scientific Society Press and Karger; 1991:185-201.
34. Sato S., Malow B.A. Benzodiazepines. Levy R.H., Mattson R.H., Meldrum B.S. Antiepileptic drugs. 4th ed:1995;725-734 Raven Press, New York.
35. Scheel-Krüger J. Dopamine-GABA interaction. Evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system Acta Neural Scand. Suppl. 302:1986;1-54.
36. Stewart J.S., Druhan J.P. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology (Berlin). 110:1993;125-132.
37. B receptors originate from discrete afferent neurons. Neurosci. Lett. 134:1992;207-211.
38. Westerberg Y., Corcoran M.E. Antagonism of central but not peripheral cholinergic receptors retards amygdala kindling in rats. Exp. Neurol. 95:1987;194-206.
39. Wolf M.E., Khansa M.R. Administration of MK-801 produces sensitization to its own stimulant effects but blocks sensitization to amphetamine. Brain Res. 562:1991;164-168.